GRACE
C

Surgery for Lung Cancer: Types and Considerations

By GRACE FEATURING Chi-Fun Jeffery Yang
By GRACE FEATURING Chi-Fun Jeffery Yang
85 views
February 15, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
35:40
Balazs Halmos

Year in Review: Lung Cancer

17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
27:04
Fengting Yan

Cancer Screening Molecular Tools

25:35
Total Health

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Feat. S. Kazmi
08:49
David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

25:18
Janakiraman Subramanian

Updates in Small Cell Lung Carcinoma

18:35
2023 Evolution Conference

Recent Updates in SCLC

Feat. S. Kazmi
30:27
Insights from 2023 ESMO Annual Meeting

Perioperative Immunotherapy Strategies in Resectable NSCLC After ESM…

Feat. G. Mountzios
07:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…

Feat. J. West
16:12
Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon
05:02
GRACE

Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC

Feat. A. Desai
23:32
2023 West Oncology Conference

2023 Updates on Neoadjuvant and Adjuvant NSCLC

Feat. M. Johnson
11:50
GRACE

The CheckMate 816 Trial: The Success of Neoadjuvant NSCLC Therapies

Feat. J. Rotow
22:57
Total Health

Lung Cancer Screening - Best of Lung 2023

Feat. C. Olazagasti
20:27
Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst
54:26
Yale Cancer Center

Year in Review: Progress in NSCLC Treatment

Feat. R. Herbst
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

23:36
CHEST 2022 Coverage

Immune Checkpoint Inhibitor Pneumonitis in Lung Cancer

Feat. J. Possick
21:24
Chul Kim

ADCs and Bispecific Inhibitors in NSCLC